CNE100005RD2
CNE100005RD2
MABWELL (SHANGHAI) BIOSCIENCE C
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 11.07B EUR | 12.62B EUR | 14.39B EUR |
Enterprise Value | 12.21B EUR | 13.69B EUR | 16.09B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | -23.6x | -- | -- |
Price to Sales | 12.67x | 27.1x | 44.22x |
Price to Book | 12.64x | 14.45x | 134.72x |
EV/Revenue | 13.98x | 29.41x | 49.45x |
EV/EBITDA | -19.16x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -7.1% | -5.18% | -4.27% |